Showing results (511-520 of 671) with videos related to

Sort By:
Pageof 68
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotypeChung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2020
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse]Yu-Hong Chen, Lan-Ping Xu, Huan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trialChen-Hua Liu, Chun-Jen Liu, Chih-Lin Lin, et al.
Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Pageof 68